Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion.
about
Macular grid laser photocoagulation for branch retinal vein occlusionAnti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusionThe safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic reviewProtocol: Effect of intravitreal bevacizumab (avastin) in the treatment of macular edema: A systematic review of randomized controlled trialsManagement of macular edema secondary to branch retinal vein occlusion: an evidence-based update.Efficacy of combined intravitreal bevacizumab and triamcinolone for branch retinal vein occlusion.Intravitreal injection of bevacizumab combined with macular grid laser photocoagulation for macular edema in branch retinal vein occlusion.Recurrence of macular edema associated with branch retinal vein occlusion after intravitreal bevacizumab.Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review.Intravitreal bevacizumab treatment for macular edema due to branch retinal vein occlusion in a clinical setting.Short-duration focal pattern grid photocoagulation for macular edema secondary to branch retinal vein occlusion.Branch retinal vein occlusion: treatment modalities: an update of the literature.Efficacy and safety of intravitreal therapy in macular edema due to branch and central retinal vein occlusion: a systematic review.Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trial.The influence of anti-VEGF therapy on present day management of macular edema due to BRVO and CRVO: a longitudinal analysis on visual function, injection time interval and complications.Comparative efficacy and safety of approved treatments for macular oedema secondary to branch retinal vein occlusion: a network meta-analysis.Intravitreal steroid and anti-vascular endothelial growth agents for the management of retinal vein occlusion: evidence from randomized trials.Comparison between anti-VEGF therapy and corticosteroid or laser therapy for macular oedema secondary to retinal vein occlusion: A meta-analysis.The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand's pharmaceutical benefit package.Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion.Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review.Initial dose of three monthly intravitreal injections versus PRN intravitreal injections of bevacizumab for macular edema secondary to branch retinal vein occlusion.Effects of two different doses of intravitreal bevacizumab on subfoveal choroidal thickness and retinal vessel diameter in branch retinal vein occlusion.Visual acuity following intravitreal bevacizumab for macular edema associated with retinal vein occlusion.“Off-label” use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.The use of bevacizumab and ranibizumab for branch retinal vein occlusion in medicare beneficiaries.Update in the Management of Macular Edema Following Retinal Vein Occlusions
P2860
Q24187991-2FFF3DC5-64B8-4A2B-97C0-AD37AFB6ED24Q24201821-CAA8A684-1BB0-43EF-B337-5535D1D6CD06Q27013836-B45C135C-ED0D-449B-BB55-2716BAA11E31Q28680651-9B23AE2A-0BA4-4ED6-A0FE-70891A76D7E3Q33770558-3DFA187F-DBCC-4A99-99BA-C20A300127E7Q33780636-07D17745-BAB4-47C0-86D4-3C0A8616955FQ34016748-A150A120-D19C-4F47-B158-CD57D4BDDBDFQ34106112-5B584986-05DA-4125-8AB2-9DAE88CAC6F0Q34249087-FBA338F3-7571-44EF-9261-8445A2579E57Q34293412-083ACC49-ED3C-4F55-BEC3-1747BFD8CBE8Q34333307-3FF4C53D-84EF-478E-A5B1-1D1F2267A9B6Q35028773-4C01037F-5CBF-4727-BC76-56F3C28103ECQ35036495-4B05226F-5C01-4F99-AA8A-7A1FAED1E15EQ35209724-4577011A-8787-4FA1-8C60-22DCEA2DDF81Q35269542-17B63C38-BDF8-451C-B7BB-50D15F028E41Q35655005-5EFB73BD-08F6-417C-BA8A-F0D7B838CA15Q35769968-EDBC0906-09E9-44F7-B88B-554239A52D89Q36412013-9D658300-8E92-4CE9-806F-3CA8B1F65899Q36461851-0A2D6359-D3DC-44D8-9E61-D7040743E1B5Q36835209-D06ACA27-942C-4474-80D9-59977B3F14EFQ37523465-87D1E9E4-69C4-430C-B11E-0190C0DA2F37Q42181848-84C03ED1-EB42-4A90-B7AD-02375D0362B9Q42412682-F74A546F-080A-4A67-8A96-5A86F4E69332Q42770019-787B94EB-6772-4E6A-8183-E48AB3F3423EQ47140209-5FC1FA7F-F8C9-4839-9604-7227004B2C19Q55551050-219BE91F-7909-4CCD-9CD8-0FD1E9BB57DAQ57827814-E10A3A32-65E5-486E-9DD3-7EAA26AD6BB6
P2860
Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Bevacizumab compared with macu ...... branch retinal vein occlusion.
@ast
Bevacizumab compared with macu ...... branch retinal vein occlusion.
@en
type
label
Bevacizumab compared with macu ...... branch retinal vein occlusion.
@ast
Bevacizumab compared with macu ...... branch retinal vein occlusion.
@en
prefLabel
Bevacizumab compared with macu ...... branch retinal vein occlusion.
@ast
Bevacizumab compared with macu ...... branch retinal vein occlusion.
@en
P2093
P1433
P1476
Bevacizumab compared with macu ...... branch retinal vein occlusion.
@en
P2093
Andrea Stella
Antonio Barone
Emanuele Conte
Francesco Prascina
Nicola Delle Noci
Vincenzo Russo
P304
P356
10.1097/IAE.0B013E318195CA65
P577
2009-04-01T00:00:00Z